SC
ARKG icon

Scotia Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Scotia Capital’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,871
Closed -$483K – 860
2024
Q3 		$483K Buy
+18,871
New +$481K ﹤0.01% 624
2024
Q2 		– Sell
-8,695
Closed -$250K – 830
2024
Q1 		$250K Buy
8,695
+1,339
+18% +$40.3K ﹤0.01% 721
2023
Q4 		$241K Buy
+7,356
New +$200K ﹤0.01% 704
2023
Q3 		– Sell
-6,994
Closed -$238K – 781
2023
Q2 		$238K Sell
6,994
-134
-2% -$4.21K ﹤0.01% 697
2023
Q1 		$214K Sell
7,128
-12
-0.2% -$372 ﹤0.01% 702
2022
Q4 		$202K Sell
7,140
-14,235
-67% -$452K ﹤0.01% 720
2022
Q3 		$703K Buy
21,375
+506
+2% +$18.6K 0.01% 498
2022
Q2 		$657K Sell
20,869
-271
-1% -$9.48K ﹤0.01% 530
2022
Q1 		$971K Sell
21,140
-28,577
-57% -$1.36M 0.01% 517
2021
Q4 		$3.04M Sell
49,717
-336
-0.7% -$23.2K 0.02% 338
2021
Q3 		$3.74M Buy
50,053
+3,177
+7% +$267K 0.03% 284
2021
Q2 		$4.34M Buy
46,876
+2,435
+5% +$207K 0.03% 265
2021
Q1 		$3.94M Buy
44,441
+22,427
+102% +$2.22M 0.03% 266
2020
Q4 		$2.05M Buy
22,014
+13,365
+155% +$1.06M 0.02% 325
2020
Q3 		$551K Buy
8,649
+1,064
+14% +$62.3K 0.01% 485
2020
Q2 		$396K Buy
+7,585
New +$325K 0.01% 463

Other funds holding ARKG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Scotia Capital's ARKG Position: Q4 2024 in Review

Scotia Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2024, closing a stake of 18,871 shares — an estimated $483K sold.

Scotia Capital first reported a position in ARKG in Q2 2020 and held it in 16 quarters. The position peaked at $4.34M in Q2 2021. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2024.

  • Scotia Capital reported no remaining ARK Genomic Revolution ETF position as of Q4 2024 after selling out during the quarter.
  • Scotia Capital sold 18,871 ARK Genomic Revolution ETF shares in Q4 2024, an estimated $483K.
  • Scotia Capital first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 16 quarters.
  • Scotia Capital's ARK Genomic Revolution ETF position peaked at $4.34M in Q2 2021.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2024.

Based on Scotia Capital's 13F filing for Q4 2024, filed 13 Feb 2025.